Skip to content

The primary headaches with fibromyalgia: a cross-sectional study

The primary headaches with fibromyalgia: a cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034894
Enrollment
Unknown
Registered
2020-07-23
Start date
2020-08-31
Completion date
Unknown
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The primary headaches with fibromyalgia

Interventions

case series:Nil

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients of 18-75 years old; 2. Patients diagnosed as primary headache (with or without overdose) based on medical history; 3. Patients with history of headache for more than one year; 4. Patients who signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Repeated patients; 2. Patients who have taken drugs that have a therapeutic effect on fibromyalgia in the past week; *Fibromyalgia treatment drugs: calcium channel modulators (such as pregabalin, gabapentin, etc.), SNRIs (such as duloxetine, venlafaxine, etc.), tricyclic antidepressants (such as amitriptyline, etc.) ), SSRIs (such as fluoxetine, sertraline, etc.), muscle relaxants (such as cyclobenzaprine). 3. Patients who cannot understand the questionnaire.

Design outcomes

Primary

MeasureTime frame
FiRST Screening Questionnaire;;SEN, SPE, ACC, AUC of ROC;

Secondary

MeasureTime frame
Hospital Anxiety and Depression Scale (HADS);

Countries

China

Contacts

Public ContactShengyuan Yu

Chinese PLA General Hospital

yusy1963@126.com+86 13501171068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026